A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Clinical trial NCT02157103 · COMPLETED
Trial details
- NCT number
- NCT02157103
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.